Table 3.
Multivariate analysis.
| Variates | Model I | Model II | Model III | |||
|---|---|---|---|---|---|---|
| OR (95% CI) | P -value | OR (95% CI) | P -value | OR (95% CI) | P -value | |
| BMI | 0.876 (0.773–0.986) | 0.031 | 0.895 (0.752–1.039) | 0.174 | 0.774 (0.626–0.934) | 0.011 |
| eGFR, per 10 mL/min/1.732 m2 | 1.325 (1.022–1.777) | 0.044 | 1.439 (1.025–2.186) | 0.055 | 1.390 (1.005–2.060) | 0.066 |
| Cholesterol, per mmol/L | 1.541 (1.063–2.283) | 0.026 | 1.787 (1.160–2.885) | 0.011 | 2.320 (1.398–4.171) | 0.002 |
| ACEI/ARB | 3.763 (1.524–9.908) | 0.005 | 10.149 (3.238–39.393) | <0.001 | 7.934 (2.334–32.095) | 0.002 |
| EDVI, per 10 ml/m2 | 0.824 (0.685–0.979) | 0.033 | 0.786 (0.627–0.961) | 0.025 | 0.777 (0.613–0.956) | 0.024 |
| CgB, per 100 pg/mL | 0.832 (0.760–0.895) | <0.001 | 0.699 (0.544–0.831) | 0.001 | ||
| Collateral conditions | 0.109 (0.007–1.192) | 0.090 | ||||
| CgB × Collateral conditions | 1.338 (1.056–1.821) | 0.037 | ||||
ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; BMI, body mass index; CgB, chromogranin B; EDVI, left ventricular end-diastolic volume index; eGFR, estimated glomerular filtration rate.